Fuqiang Wen

11.9k total citations · 1 hit paper
341 papers, 6.7k citations indexed

About

Fuqiang Wen is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Physiology. According to data from OpenAlex, Fuqiang Wen has authored 341 papers receiving a total of 6.7k indexed citations (citations by other indexed papers that have themselves been cited), including 183 papers in Pulmonary and Respiratory Medicine, 92 papers in Molecular Biology and 67 papers in Physiology. Recurrent topics in Fuqiang Wen's work include Chronic Obstructive Pulmonary Disease (COPD) Research (88 papers), Asthma and respiratory diseases (50 papers) and Respiratory Support and Mechanisms (37 papers). Fuqiang Wen is often cited by papers focused on Chronic Obstructive Pulmonary Disease (COPD) Research (88 papers), Asthma and respiratory diseases (50 papers) and Respiratory Support and Mechanisms (37 papers). Fuqiang Wen collaborates with scholars based in China, United States and Japan. Fuqiang Wen's co-authors include Tao Wang, Yongchun Shen, Stephen I. Rennard, Xiangde Liu, Tadashi Kohyama, Tetsu Kobayashi, Dan Xu, Chun Wan, Qiuhong Fang and Shinji Abe and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and American Journal of Respiratory and Critical Care Medicine.

In The Last Decade

Fuqiang Wen

328 papers receiving 6.6k citations

Hit Papers

The Multifaceted Therapeutic Role of N-Acetylcysteine (NA... 2020 2026 2022 2024 2020 50 100 150

Peers

Fuqiang Wen
Irina Petrache United States
Fuqiang Wen
Citations per year, relative to Fuqiang Wen Fuqiang Wen (= 1×) peers Irina Petrache

Countries citing papers authored by Fuqiang Wen

Since Specialization
Citations

This map shows the geographic impact of Fuqiang Wen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fuqiang Wen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fuqiang Wen more than expected).

Fields of papers citing papers by Fuqiang Wen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fuqiang Wen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fuqiang Wen. The network helps show where Fuqiang Wen may publish in the future.

Co-authorship network of co-authors of Fuqiang Wen

This figure shows the co-authorship network connecting the top 25 collaborators of Fuqiang Wen. A scholar is included among the top collaborators of Fuqiang Wen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fuqiang Wen. Fuqiang Wen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zheng, Jinping, Fuqiang Wen, Chaojie Liu, et al.. (2025). Differential Decline in FEV1 and FVC Across COPD GOLD Grades and Non-Obstructed Chronic Bronchitis. American Journal of Respiratory and Critical Care Medicine. 211(Supplement_1). A6185–A6185.
2.
Wang, Shuyan, Tingting Zeng, Jiangyue Qin, et al.. (2024). A simple and efficient clinical prediction scoring system to identify malignant pleural effusion. Therapeutic Advances in Respiratory Disease. 18. 2683802330–2683802330. 2 indexed citations
3.
Li, Xiaoou, Yongchun Shen, Jiahan Cheng, et al.. (2024). Differential expression profiles and functional prediction of circular RNAs in lung cancer patients with chronic obstructive pulmonary disease: a pilot study. General Physiology and Biophysics. 43(4). 273–289.
4.
Huang, Ke, Xueyan Han, Jianping Zhao, et al.. (2024). Impact of Using Pre- and Postbronchodilator Spirometry Reference Values in a Chinese Population. American Journal of Respiratory and Critical Care Medicine. 210(7). 881–889. 1 indexed citations
5.
Yang, Ting, Baiqiang Cai, Bin Cao, et al.. (2023). REALizing and improving management of stable COPD in China: results of a multicentre, prospective, observational study (REAL). Therapeutic Advances in Respiratory Disease. 17. 2683758020–2683758020. 5 indexed citations
6.
Yang, Ting, Baiqiang Cai, Bin Cao, et al.. (2023). Exacerbation in patients with stable COPD in China: analysis of a prospective, 52-week, nationwide, observational cohort study (REAL). Therapeutic Advances in Respiratory Disease. 17. 2683746681–2683746681. 5 indexed citations
7.
Wang, Tao, Fuqiang Wen, Michael J. Sanderson, et al.. (2023). Inherent differences of small airway contraction and Ca2+ oscillations in airway smooth muscle cells between BALB/c and C57BL/6 mouse strains. Frontiers in Cell and Developmental Biology. 11. 1202573–1202573. 9 indexed citations
8.
Tanna, Gian Luca Di, Anish Scaria, Allison Martin, et al.. (2022). Blood Eosinophils in Chinese COPD Participants and Response to Treatment with Combination Low-Dose Theophylline and Prednisone: A Post-Hoc Analysis of the TASCS Trial. SHILAP Revista de lepidopterología. 2 indexed citations
9.
Xu, Dan, et al.. (2022). DKK1 Positively Correlates with Lung Function in COPD Patients and Reduces Airway Inflammation. SHILAP Revista de lepidopterología. 5 indexed citations
10.
Huang, Ke, Kewu Huang, Jianying Xu, et al.. (2021). Anxiety and Depression in Patients with Chronic Obstructive Pulmonary Disease in China: Results from the China Pulmonary Health [CPH] Study. SHILAP Revista de lepidopterología. 15 indexed citations
11.
Wang, Ke, et al.. (2021). Circadian clock dysfunction of epithelial cells in pulmonary diseases. The International Journal of Biochemistry & Cell Biology. 141. 106110–106110. 6 indexed citations
12.
Yang, Deqing, Tao Wang, Dan Xu, et al.. (2021). Mitochondrial‐Targeting Antioxidant SS‐31 Suppresses Airway Inflammation and Oxidative Stress Induced by Cigarette Smoke. Oxidative Medicine and Cellular Longevity. 2021(1). 6644238–6644238. 27 indexed citations
13.
Raghu, Ganesh, Michael Berk, Peter A. Campochiaro, et al.. (2020). The Multifaceted Therapeutic Role of N-Acetylcysteine (NAC) in Disorders Characterized by Oxidative Stress. Current Neuropharmacology. 19(8). 1202–1224. 190 indexed citations breakdown →
14.
Kang, Jian, Jinping Zheng, Baiqiang Cai, et al.. (2020). Current situation of asthma–COPD overlap in Chinese patients older than 40 years with airflow limitation: a multicenter, cross-sectional, non-interventional study. Therapeutic Advances in Respiratory Disease. 14. 3272696739–3272696739. 5 indexed citations
15.
Wen, Fuqiang, et al.. (2019). miR-373 promotes neuroblastoma cell proliferation, migration, and invasion by targeting SRCIN1. SHILAP Revista de lepidopterología. 1 indexed citations
16.
Li, Diandian, Yongchun Shen, Xiaomin Fu, et al.. (2015). Combined detections of interleukin-33 and adenosine deaminase for diagnosis of tuberculous pleural effusion.. PubMed Central. 8(1). 888–93. 15 indexed citations
17.
Liu, Lian, Xiaoou Li, Tao Wang, Lingli Guo, & Fuqiang Wen. (2014). Chrysin reduces the degree of lung injure which induced by lipopolysaccharides (LPS): Possible involvement of oxidative stress and the NF-κB pathway. European Respiratory Journal. 44(Suppl 58). P3938–P3938. 1 indexed citations
18.
Li, Diandian, Yongchun Shen, & Fuqiang Wen. (2013). A forgotten swab in bronchus for 19 years. Chinese Medical Journal. 126(6). 1118–1118. 1 indexed citations
19.
Zhou, Qingtao, et al.. (2013). Chronic obstructive pulmonary disease assessment test score correlated with dyspnea score in a large sample of Chinese patients. Chinese Medical Journal. 126(1). 11–15. 21 indexed citations
20.
Chen, Xuerong, Zongde Zhang, Chuanyou Li, et al.. (2009). [A study on the haplotype of the solute carrier family 11 member 1 gene in Tibetan patients with pulmonary tuberculosis in China].. PubMed. 32(5). 360–4. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026